OXYCODONE HCl C-II Tablets — Class II drug recall D-1150-2015
Terminated recall by The Harvard Drug Group, LLC, reported 2015-07-08, distributed nationwide. Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl
| Recall number | D-1150-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | The Harvard Drug Group, LLC, Livonia, MI, United States |
| Recall initiated | 2015-06-10 |
| Classified | 2015-06-29 |
| Reported by FDA | 2015-07-08 |
| Terminated | 2016-09-12 |
| Distributed | Nationwide (US) |
| Quantity | 12,717 tablets |
| Reason classes | potency |
| NDC | 00904-6444-61 |
| Lot numbers | 08/16, P-20000, P-20004 |
Product
OXYCODONE HCl C-II Tablets, 5 mg USP, 100-count blister cards, Rx only, Manufactured by Nesher Pharmaceuticals USA LLC., St. Louis, MO 63044, Distributed by Major Pharmaceuticals, Livonia, MI 48150, NDC 0904-6444-61.
Reason for recall
Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1150-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.